Edition:
United States

scPharmaceuticals Inc (SCPH.OQ)

SCPH.OQ on NASDAQ Stock Exchange Global Market

4.76USD
7 Dec 2018
Change (% chg)

-- (--)
Prev Close
$4.76
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
10,740
52-wk High
$17.71
52-wk Low
$3.85

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.00 -0.310
Jun '18 0.00 -0.531
Mar '18 0.00 -0.471
FY 2017 Dec '17 0.00 -0.371
Sep '17 0.00 -0.312
Jun '17 0.00 -0.371
Mar '17 0.00 -0.279
FY 2016 Dec '16 0.00 -0.302
Sep '16 0.00 -0.516
Jun '16 0.00 -1.575
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 3 0.00 0.00 0.00 --
Quarter Ending Mar-19 1 0.00 0.00 0.00 --
Year Ending Dec-18 3 0.00 0.00 0.00 --
Year Ending Dec-19 3 0.00 0.00 0.00 --
Earnings (per share)
Quarter Ending Dec-18 3 -0.44 -0.42 -0.47 --
Quarter Ending Mar-19 1 -0.43 -0.43 -0.43 --
Year Ending Dec-18 3 -1.75 -1.73 -1.78 --
Year Ending Dec-19 3 -2.02 -1.82 -2.23 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 32.18 33.63
P/E High - Last 5 Yrs. -- 40.37 45.43
P/E Low - Last 5 Yrs. -- 19.62 24.43
Beta -- 0.79 0.90
Price to Sales (TTM) -- 6.70 5.77
Price to Book (MRQ) -- 4.95 5.12
Price to Tangible Book (MRQ) -- 16.61 6.54
Price to Cash Flow (TTM) -- 21.70 23.57
% Owned Institutions -- 4.58 1.83

Dividends

  Company industry sector
Dividend Yield -- 1.05 1.49
Dividend Yield - 5 Year Avg -- 1.25 1.50
Dividend 5 Year Growth Rate -- 16.25 5.08
Payout Ratio(TTM) -- 30.79 43.75

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 8.68 7.43
Sales (TTM) vs TTM 1 Yr. Ago -- 2.18 5.80
Sales - 5 Yr. Growth Rate -- 8.65 10.19
EPS (MRQ) vs Qtr. 1 Yr. Ago -- 60.04 21.03
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 19.65 10.79
Capital Spending - 5 Yr. Growth Rate -- 7.92 15.12

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.44 2.28
Current Ratio (MRQ) -- 3.16 3.11
LT Debt to Equity (MRQ) -- 29.39 11.47
Total Debt to Equity (MRQ) -- 36.36 15.63
Interest Coverage (TTM) -- 15.23 31.38

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 58.82 54.21
Gross Margin - 5 Yr. Avg. -- 58.30 51.98
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 22.93 11.83
Operating Margin (TTM) -- 17.67 4.90
Operating Margin - 5 Yr. Avg. -- 15.83 7.44
Pre-Tax Margin (TTM) -- 17.43 5.91
Pre-Tax Margin - 5 Yr. Avg. -- 16.10 7.89
Net Profit Margin (TTM) -- 13.32 2.16
Net Profit Margin - 5 Yr. Avg. -- 11.25 4.12
Effective Tax Rate (TTM) -- 23.22 23.36
Effective Tax Rate - 5 Yr. Avg. -- 28.91 24.15

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 28,806,629 898,926,015
Net Income/Employee (TTM) -- 3,198,980 106,550,787
Receivable Turnover (TTM) -- 5.07 5.94
Inventory Turnover (TTM) -- 3.28 3.62
Asset Turnover (TTM) -- 0.79 0.97

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 10.48 11.50
Return on Assets - 5 Yr. Avg. -- 8.98 12.67
Return on Investment (TTM) -- 13.76 15.02
Return on Investment - 5 Yr. Avg. -- 11.64 16.45
Return on Equity (TTM) -- 16.50 16.60
Return on Equity - 5 Yr. Avg. -- 13.94 17.56

Performance for scPharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 78.27%
# of Holders: 60
Total Shares Held: 14,534,700
3 Mo. Net Change: -34,528
# New Positions: 4
# Closed Positions: 9
# Increased Positions: 24
# Reduced Positions: 19
# Net Buyers: 5
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.